Work

KEYNOTE-905: A phase III study of cystectomy plus perioperative pembrolizumab versus cystectomy alone in cisplatin (cis)-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC)

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz249.085

Authors: M. Galsky, A. Necchi, N.D. Shore, F. Witjes, K. Nam, J.L. Godwin, T.L. Frenkl, E.R. Plimack

Institutions: Mount Sinai Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Fondazione IRCCS Istituto Nazionale dei Tumori, Carolina Urologic Research Center, Radboud University Nijmegen, Radboud University Medical Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Fox Chase Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, AstraZeneca, Incyte

OpenAlex ID: W2979058581

FWCI: 0.216

Cites:

Cited by: 1

Related to: 10